In conclusion, despite the limitations listed above, this meta-analysis showed that Twist overexpression is correlated with poor OS and clinicopathological features in NSCLC, suggesting that the Twist may be a poor prognostic factor and therapeutic target in NSCLC. The gene discussed is TWIST1; the disease is non-small cell lung carcinoma.